Cargando…
RBM23 Drives Hepatocellular Carcinoma by Activating NF-κB Signaling Pathway
PURPOSE: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and angiogenesis has been proven to be significantly involved in its progression. However, the molecular mechanism underlying HCC angiogenesis has not been well researched. In this study, RNA Binding Motif...
Autores principales: | Han, Hexu, Lin, Ting, Fang, Ziyi, Zhou, Guoxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994101/ https://www.ncbi.nlm.nih.gov/pubmed/33791378 http://dx.doi.org/10.1155/2021/6697476 |
Ejemplares similares
-
PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway
por: Tang, Xuming, et al.
Publicado: (2020) -
COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells
por: Zheng, Lu, et al.
Publicado: (2018) -
Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway
por: Shen, Ze-Tian, et al.
Publicado: (2019) -
miR-383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24-mediated NF-κB signaling pathway
por: He, Bo, et al.
Publicado: (2021) -
Paeonol-mediated apoptosis of hepatocellular carcinoma cells by NF-κB pathway
por: Li, Qiang, et al.
Publicado: (2019)